How does regulating doctors' admissions affect health expenditures? Evidence from Switzerland

Michel Fuino1, Philipp Trein2, Joël Wagner1,3

  • 1Department of Actuarial Science, University of Lausanne, Chamberonne - Extranef, Lausanne, 1015, Switzerland.

Insights

Switzerland

Area of Science:

  • Health policy research
  • Healthcare economics
  • Public health regulation

Background:

  • Cost containment is a critical global health policy challenge.
  • Switzerland has implemented moratoriums on physician admissions to control costs.
  • These regulations target both specialist and general practitioner (GP) numbers.

Purpose of the Study:

  • To evaluate the impact of Swiss moratoriums on physician supply and healthcare costs.
  • To analyze the effects of national and cantonal-level regulations.
  • To inform health policy decisions regarding cost containment strategies.

Main Methods:

  • Analysis of Swiss health insurer data (SASIS) from 2007-2018.
  • Utilized interrupted time series and difference-in-differences models.
  • Examined physician billing numbers and direct medical costs.

Main Results:

  • Lifting the national moratorium in 2012 increased physician numbers without significantly raising costs.
  • Reintroducing cantonal moratoriums in 2013-2014 reduced physician numbers.
  • Cantonal regulations also did not significantly impact direct health costs.

Conclusions:

  • Physician admission moratoriums do not appear to be an effective tool for directly controlling healthcare expenditure growth.
  • Healthcare supply regulation via moratoriums has a limited impact on overall health costs.
  • Policy interventions need to consider broader factors influencing health spending.
Abstract

Related Concept Videos

Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
267
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.9K
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.6K
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
186